» Articles » PMID: 20691899

Direct Reprogramming of Fibroblasts into Functional Cardiomyocytes by Defined Factors

Overview
Journal Cell
Publisher Cell Press
Specialty Cell Biology
Date 2010 Aug 10
PMID 20691899
Citations 1209
Authors
Affiliations
Soon will be listed here.
Abstract

The reprogramming of fibroblasts to induced pluripotent stem cells (iPSCs) raises the possibility that a somatic cell could be reprogrammed to an alternative differentiated fate without first becoming a stem/progenitor cell. A large pool of fibroblasts exists in the postnatal heart, yet no single "master regulator" of direct cardiac reprogramming has been identified. Here, we report that a combination of three developmental transcription factors (i.e., Gata4, Mef2c, and Tbx5) rapidly and efficiently reprogrammed postnatal cardiac or dermal fibroblasts directly into differentiated cardiomyocyte-like cells. Induced cardiomyocytes expressed cardiac-specific markers, had a global gene expression profile similar to cardiomyocytes, and contracted spontaneously. Fibroblasts transplanted into mouse hearts one day after transduction of the three factors also differentiated into cardiomyocyte-like cells. We believe these findings demonstrate that functional cardiomyocytes can be directly reprogrammed from differentiated somatic cells by defined factors. Reprogramming of endogenous or explanted fibroblasts might provide a source of cardiomyocytes for regenerative approaches.

Citing Articles

Ubiquitous MEIS transcription factors actuate lineage-specific transcription to establish cell fate.

Darieva Z, Zarrineh P, Phillips N, Mallen J, Garcia Mora A, Donaldson I EMBO J. 2025; .

PMID: 40021842 DOI: 10.1038/s44318-025-00385-5.


Direct fibroblast reprogramming: an emerging strategy for treating organic fibrosis.

Lin H, Wang X, Chung M, Cai S, Pan Y J Transl Med. 2025; 23(1):240.

PMID: 40016790 PMC: 11869441. DOI: 10.1186/s12967-024-06060-3.


Emerging Insights into Sall4's Role in Cardiac Regenerative Medicine.

Yang J Cells. 2025; 14(3).

PMID: 39936946 PMC: 11817359. DOI: 10.3390/cells14030154.


Decoding the epigenetic and transcriptional basis of direct cardiac reprogramming.

Peng W, Getachew A, Zhou Y Stem Cells. 2025; 43(3).

PMID: 39851272 PMC: 11904897. DOI: 10.1093/stmcls/sxaf002.


Interplay between pioneer transcription factors and epigenetic modifiers in cell reprogramming.

Mirizio G, Sampson S, Iwafuchi M Regen Ther. 2025; 28():246-252.

PMID: 39834592 PMC: 11745816. DOI: 10.1016/j.reth.2024.12.014.


References
1.
Hudon-David F, Bouzeghrane F, Couture P, Thibault G . Thy-1 expression by cardiac fibroblasts: lack of association with myofibroblast contractile markers. J Mol Cell Cardiol. 2007; 42(5):991-1000. DOI: 10.1016/j.yjmcc.2007.02.009. View

2.
Bruneau B, Nemer G, Schmitt J, Charron F, Robitaille L, Caron S . A murine model of Holt-Oram syndrome defines roles of the T-box transcription factor Tbx5 in cardiogenesis and disease. Cell. 2001; 106(6):709-21. DOI: 10.1016/s0092-8674(01)00493-7. View

3.
Gulick J, Subramaniam A, Neumann J, Robbins J . Isolation and characterization of the mouse cardiac myosin heavy chain genes. J Biol Chem. 1991; 266(14):9180-5. View

4.
Hong H, Takahashi K, Ichisaka T, Aoi T, Kanagawa O, Nakagawa M . Suppression of induced pluripotent stem cell generation by the p53-p21 pathway. Nature. 2009; 460(7259):1132-5. PMC: 2917235. DOI: 10.1038/nature08235. View

5.
Lin Q, Schwarz J, Bucana C, Olson E . Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C. Science. 1997; 276(5317):1404-7. PMC: 4437729. DOI: 10.1126/science.276.5317.1404. View